Provided by Tiger Trade Technology Pte. Ltd.

GENFLEET-B

33.000
+3.42011.56%
Volume:5.46M
Turnover:175.06M
Market Cap:12.64B
PE:-5.44
High:33.400
Open:30.000
Low:29.560
Close:29.580
52wk High:52.900
52wk Low:19.600
Shares:383.00M
HK Float Shares:351.00M
Volume Ratio:1.54
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-6.070
ROE:--
ROA:-19.54%
PB:6.73
PE(LYR):-5.44
PS:128.69

Loading ...

Hong Kong Stock Market News Roundup: Insilico Medicine Secures Multi-Million-Dollar AI Collaboration Deal

Stock News
·
Sep 22

GenFleet Therapeutics’ GFH375-Cetuximab Regimen Advances to China’s Proposed Breakthrough Therapy List

Bulletin Express
·
Sep 22

Genfleet Therapeutics (Shanghai) - Gfh375 Combined with Cetuximab Placed on Proposed Breakthrough Therapy Designation List by Nmpa on SEP 18

THOMSON REUTERS
·
Sep 22

HK-Listed GenFleet Rises Most in a Month on Repurchasing Shares

Reuters
·
Sep 21

GENFLEET-B (02595) Posts HK$1.125 Billion Transfer in Share Movement, Accounting for 12.80% of Holdings

Stock News
·
Sep 21

GENFLEET-B Announces H-Share Buyback Totaling 872,000 Shares as of September 18

Stock News
·
Sep 21

GenFleet Reports Progress on 2026 H-Share Buyback: 872,000 Shares Repurchased, Equal to 0.227% of Share Capital

Bulletin Express
·
Sep 21

GenFleet Therapeutics Repurchases 319,000 H-Shares for HK$8.12 Million

Bulletin Express
·
Sep 18

GENFLEET-B Repurchases 63,000 Shares for Approximately HK$1.57 Million

Stock News
·
Sep 17

GenFleet Therapeutics Executes HKD 4.22 Million Share Buyback, Reducing Free Float by 0.048%

Bulletin Express
·
Sep 16

GENFLEET-B (02595) Spends Approximately HK$4.22 Million on Share Buyback on September 16

Stock News
·
Sep 16

GenFleet Therapeutics 1H26: Loss Contracts to RMB 220.17 million as Cash Reserves Hold at RMB 1.78 billion

Bulletin Express
·
Sep 16

GenFleet Therapeutics Executes 50,000-Share Buyback, Outstanding H-Share Float Slips to 351.31 Million

Bulletin Express
·
Sep 15

GENFLEET-B Buys Back 50,000 Shares for HK$1.30 Million on September 15

Stock News
·
Sep 15

GenFleet Presents Updated Lung Cancer Therapy Data at Korean Medical Conference

MT Newswires Live
·
Sep 15

GENFLEET-B (02595) Presents Encouraging Phase II Monotherapy Results for Oral KRAS G12D Inhibitor in Pretreated NSCLC at WCLC 2026

Stock News
·
Sep 15

GenFleet posts 59.2% ORR for oral KRAS G12D inhibitor GFH375 in Phase II NSCLC trial presented at WCLC 2026

Bulletin Express
·
Sep 15

Shares Slip 20% in One-Sided Slide, When Will the Bounce Arrive for GENFLEET-B (02595) After Deposit Shift?

Stock News
·
Sep 12

GenFleet Therapeutics Buys Back 80,000 H-Shares; Issued Share Base Slips to 351.36 Million

Bulletin Express
·
Sep 11

Genfleet Therapeutics Files HKEX Next-Day Return Disclosing Share Buyback at HKD 25.79 Each

Reuters
·
Sep 11